Manufacturers should display that any new technology or method not simply meets the existing standards for sterility assurance but also presents tangible Advantages in terms of performance, trustworthiness, or item protection. As these new technologies arise, the WHO emphasizes the significance of an intensive risk assessment and validation procedure. waiting for link from Forum Profiles (6)